Intravesical BCG: is the Urinary Bladder Ready to Receive it
NCT05335512 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-06-09
Summary
Prospective cohort and Prospective observational study which aims To define the healing time-frame of the resected area of the bladder after TURBT. and also to validate a grading system of healing of the bladder mucosa after TURBT. To assess the factors influencing bladder healing is also one of the secondary objectives.
Conditions
- Non-Invasive Bladder Urothelial Carcinoma
Sponsors & Collaborators
-
Tata Memorial Centre
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2023-09-01
- Completion
- 2028-09-01
More Related Trials
-
BCG for Therapeutic Use Phase I Clinical Trial
NCT06100653 ·Status: COMPLETED ·Phase: PHASE1
-
Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection
NCT02202044 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer
NCT05580354 ·Status: UNKNOWN ·Phase: PHASE4
-
Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer
NCT00696579 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
URO-BCG-4 : Bladder Tumors Immunotherapy
NCT00213655 ·Status: COMPLETED
-
Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study
NCT04194112 ·Status: COMPLETED ·Phase: NA
-
Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study
NCT06990061 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder Cancer
NCT05675176 ·Status: COMPLETED
-
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
NCT02138734 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Oncological Outcomes of Different Patterns of Tumor Recurrence at First Evaluation After Bacillus Calmette-Guérin Induction Therapy for Intermediate and High Risk Non Muscle Invasive Bladder Cancer
NCT04319263 ·Status: COMPLETED ·Phase: NA
-
In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?
NCT03174912 ·Status: COMPLETED ·Phase: PHASE4
-
A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival
NCT03266900 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Immunological Response of Bladder Cancer Patients Under BCG
NCT04806178 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)
NCT05037279 ·Status: RECRUITING ·Phase: PHASE3
-
Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder
NCT00539773 ·Status: COMPLETED ·Phase: NA
-
Lower Urinary Tract Symptoms After Intravesical Therapy
NCT05844059 ·Status: RECRUITING
-
BCG for Therapeutic Use Phase Ⅲ Clinical Trial
NCT06747455 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer
NCT04726735 ·Status: COMPLETED
-
Intravesical BCG Administration to Patients With Invasive Bladder Cancer
NCT02365207 ·Status: TERMINATED ·Phase: NA
-
Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers
NCT04723121 ·Status: COMPLETED ·Phase: NA
-
BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer
NCT00352079 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
NCT05626101 ·Status: RECRUITING ·Phase: NA
-
The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer
NCT01697306 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
NCT06241755 ·Status: RECRUITING ·Phase: PHASE3
-
Biological Therapy in Treating Patients With Bladder Cancer
NCT00003779 ·Status: COMPLETED ·Phase: PHASE3